Hims & Hers director granted 8,223 RSUs
Schultz Kare reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Schultz Kare reported acquisition or exercise transactions in this Form 4 filing.
Hims & Hers Health, Inc. reported that director Schultz Kare received a grant of 8,223 Restricted Stock Units (RSUs), each representing a right to receive one share of Class A Common Stock. Subject to continuous service, these RSUs will vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2 | 8,223 | $0.00 | $0.00 |
Footnotes (2)
- F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- F2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.
Key Figures
Key Terms
Restricted Stock Unit financial
continuous service financial
annual stockholder meeting financial
quarterly vesting date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HIMS report for Schultz Kare on this Form 4?
What are the vesting conditions for Schultz Kare’s RSUs at Hims & Hers (HIMS)?
Is this HIMS Form 4 transaction under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.